Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 June 2023 | Story Nosethu Badlezana | Photo Supplied
Nosethu Badlezana
Nosethu Badlezana, Academic Facilitator: Centre for Teaching and Learning

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Nosethu Badlezana shares her UFS journey:

Q: Year of graduation from the UFS: 
A: I completed my undergraduate degree in 2015 and thereafter obtained my honours in 2016.

Q: Qualification obtained from the UFS: 
A: The first degree I obtained was a BA in Communication with specialisation in Media Studies and Journalism. I then made the decision to pursue my honours degree in the same field.

Q: Date of joining the UFS as a staff member: 
A: In 2016, I began my internship on the Qwaqwa Campus with the Centre for Teaching and Learning’s former Curriculum Delivery and Innovation Division, which is now known as the Blended Learning Innovation Support and Services Division. The following year, upon completion of my internship, I was appointed as an Assistant Officer in the Academic Language and Literacy Development Division within the same department. Then, in 2022, I was promoted to the role of Academic Facilitator.

Q: How did the UFS prepare you for the professional world?
A: During my time as a student at the UFS, I followed a comprehensive curriculum that equipped me with essential skills to thrive in a professional setting. Through a diverse range of modules, I developed proficiencies in crucial areas, including time management, effective communication, problem-solving, critical thinking, self-management, and collaborative teamwork.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member? 
A: It's a fascinating journey, one that feels like a way of giving back to the community that nurtured and shaped me. Assisting students to achieve success in higher education doesn't feel like a burden to me, as I once walked the same path as a student at this institution. The UFS has provided me with a valuable network of support and mentorship, which has been instrumental in fostering a sense of security and confidence in my chosen career path.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept